Bill
A 4759
New York bill expands medical cannabis research authority and refines therapeutic research regulations to improve treatment efficacy evaluation and clinical applications.
Assembly Bill A 4759 modifies New York's medical cannabis framework by expanding research capabilities and refining the state's Controlled Substances Therapeutic Research Act. The bill has been substituted by Senate Bill S3294A, indicating the legislative process moved to the Senate version for further consideration. The measure addresses both the efficacy of medical cannabis treatments and the regulatory structure governing therapeutic research.
Medical cannabis research authorization affects patient access to treatment options, determines which conditions qualify for cannabis therapy, and influences New York's role in national cannabis research standards. These changes could expand evidence-based treatment pathways while shaping how the state regulates emerging therapeutic applications.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
